(Q24293659)

GOA release 2020-03-11

Endothelin 1

1 reference

GOA release 2020-03-11

Endothelin 2

1 reference

primary biliary cholangitis

GOA release 2020-03-11

0 references

author name string

P Dimoulios

1

0 references

G Kolios

2

0 references

G Notas

3

0 references

E Matrella

4

0 references

C Xidakis

5

0 references

M Koulentaki

6

0 references

N Tsagarakis

7

0 references

A Kouroumalis

8

0 references

E Kouroumalis

Alimentary Pharmacology & Therapeutics

9

0 references

language of work or name

English

0 references

publication date

1 February 2005

0 references

published in

0 references

volume

21

0 references

issue

3

0 references

page(s)

227-34

0 references

cites work

Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2005.02307.X

The L-arginine-nitric oxide pathway

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2005.02307.X

Endothelins in the kidney: physiology and pathophysiology

20 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

Growth regulatory properties of endothelins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

Endothelin and the development of the enteric nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

Vascular mediators in the injured liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

Endothelins, peptides with potent vasoactive properties, are produced by human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

Detection of serum nitrite and nitrate in primary biliary cirrhosis: possible role of nitric oxide in bile duct injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

Increased nitric oxide (NO) production by antigen-presenting dendritic cells is responsible for low allogeneic mixed leucocyte reaction (MLR) in primary biliary cirrhosis (PBC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

Basic and therapeutic relevance of endothelin-mediated regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

Levels of circulating endothelin-1 and nitrates/nitrites in patients with virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

Ursodeoxycholic acid and endothelial-dependent, nitric oxide-independent vasodilatation of forearm resistance arteries in patients with coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

Endothelial cell transformation in primary biliary cirrhosis: a morphological and biochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Role of endothelins on lymphocyte accumulation in allergic pleurisy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Circulating levels of endothelin in cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Endothelin-3 like immunoreactivity in plasma of patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Increased plasma endothelin in cirrhosis. Relationship with systemic endotoxemia and response to changes in effective blood volume

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Nitric oxide synthase activity in the splanchnic vasculature of patients with cirrhosis: relationship with hemodynamic disturbances

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Treatment of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Regulation of sinusoidal perfusion: in vivo methodology and control by endothelins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Evidence of an increased nitric oxide production in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Biochemistry of Nitric Oxide and Its Redox-Activated Forms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021

Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02307.X

7 January 2021